Study Stopped
Recruition too slow
36 Versus 42 Hour Time Interval From Ovulation to Intrauterine Insemination
1 other identifier
interventional
71
1 country
1
Brief Summary
The purpose of this study is to prove that a higher clinical pregnancy rate can be achieved with a 42 to 44 hour time interval between ovulation trigger and intrauterine insemination than a 36 to 38 hour time interval in stimulated cycles utilizing gonadotropins and GnRH antagonists.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2014
CompletedFirst Posted
Study publicly available on registry
August 7, 2014
CompletedStudy Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2018
CompletedAugust 28, 2019
August 1, 2019
3.3 years
July 30, 2014
August 25, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical pregnancy rate
4 weeks following insemination
Study Arms (2)
36 hours
ACTIVE COMPARATORIntrauterine insemination 36 hours after ovulation induction
42 hours
ACTIVE COMPARATORIntrauterine insemination 42 hours after ovulation induction
Interventions
Intrauterine insemination 36 hours after ovulation induction
Intrauterine insemination 42 hours after ovulation induction
Eligibility Criteria
You may qualify if:
- Patients who can be monitored for follicle growth and hormone measurements on the day of ovulation trigger, or one day before.
- Patients who have no more than 4 follicles of 14 mm or more
- Patients who have no more than 6 follicles of 10 mm or more
You may not qualify if:
- Patients who cannot give informed consent to language or comprehension barriers
- Patients who are deemed to be at high risk for high order multiple gestations
- Patients who cannot be monitored on the day of hCG administration or one day before
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emek Medical Center
Afula, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amir Weiss, MD
Haemek Medical Center, Afula, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2014
First Posted
August 7, 2014
Study Start
January 1, 2015
Primary Completion
April 29, 2018
Study Completion
April 29, 2018
Last Updated
August 28, 2019
Record last verified: 2019-08